Grant winners – 10 September 2015

A round-up of recent recipients of research council cash

九月 10, 2015
Grant Winners header

European Research Council

Uncertainty, risk and inequality: the role of macroeconomic policies and institutions


National Institute for Health Research

Health Technology Assessment Programme

The pragmatic ischaemic thrombectomy evaluation (PISTE) trial – main phase: a randomised controlled trial of mechanical thrombectomy in acute ischaemic stroke


ALTAR: alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women


Public Health Research Programme

A cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of the GoActive programme to increase physical activity among 13- to 14-year-old adolescents


Royal Society

Wolfson Research Merit Awards

These awards are worth £10,000-£30,000 a year, which is a salary enhancement

How does social evolution generate biodiversity?


Discrete structures and randomness


Medical Research Council

Research grants

Role of growth factors of the TGFbeta superfamily in aberrant follicle development in polycystic ovary syndrome


High resolution systems biology to determine the role of gut microbiota on Type 2 diabetes


In detail

Award winner: Alex O’Neill
Institution: University of Leeds
Value: £249,823

‘Silent’ antibiotic resistance genes: an overlooked issue of considerable importance in antibacterial chemotherapy?

Antibiotics’ utility is decreasing as bacteria evolve to resist their effects, with antibiotic resistance now considered one of the three greatest threats to human health. A crucial aspect of addressing this problem is “strategic intelligence” – having current information about the proportion, in a given location, of bacterial strains resistant to particular antibiotics. This allows doctors to decide which antibiotics are best to use routinely to treat bacterial infection, and to avoid those that will probably be ineffective owing to resistance. This project will focus on investigating the phenomenon of “silencing of antibiotic resistance by mutation” (SARM) that may be undermining strategic intelligence on antibiotic resistance. Recent work has discovered that some bacteria that are sensitive to antibiotics nonetheless carry genes normally associated with antibiotic resistance, but that these genes have become switched off (“silenced”). This is deeply concerning, as bacteria with SARM would appear susceptible to an antibiotic when tested, but could then become resistant during patient treatment. Focusing on the “superbug” Staphylococcus aureus, the project aims to investigate how widespread SARM is among bacteria and how it occurs.

Please
or
to read this article.

请先注册再进行下一步

获得一个月的无限制地在线阅读网站内容。只需注册并完成您的职业简介.

注册是免费的,而且非常简单。一旦成功注册,您可以每个月免费阅读3篇文章。:

  • 获得编辑推荐文章
  • 率先获得泰晤士高等教育世界大学排名相关的新闻
  • 获得职位推荐、筛选工作和保存工作搜索结果
  • 参与读者讨论和公布评论